Results 91 to 100 of about 3,752 (164)

REGIONAL VARIABILITY IN CHOROIDAL VASCULARITY INDEX AND ASSOCIATION WITH INTERVORTEX ANASTOMOSES IN POLYPOIDAL CHOROIDAL VASCULOPATHY. [PDF]

Retina
Chong YJ, Chong Teo KY, Gilead N, Akiba M, Cheung CMG.   +4 more
europepmc   +1 more source

Management of Polypoidal choroidal vasculopathy and diabetic retinopathy: Practice patterns amongst vitreoretinal surgeons of India-A VRSI survey. [PDF]

Indian J Ophthalmol
Sindal MD, Mahendrakar P, Kothari A, Tyagi M, Mishra D, Tagare S, Vaidya M, Shanmugam M.   +7 more
europepmc   +1 more source

Juxtapillary choroidal excavation with polypoidal choroidal vasculopathy: An unusual association

Indian Journal of Ophthalmology, 2019
Maitreyi Chowdhury, Pukhraj Rishi
doaj   +1 more source

Predictive factors for the efficacy of brolucizumab in refractory polypoidal choroidal vasculopathy following aflibercept resistance. [PDF]

PLoS One
Yoshinaga A, Kitamoto K, Aoki S, Terao R, Inoue T, Obata R, Azuma K.   +6 more
europepmc   +1 more source

Polypoidal choroidal vasculopathy

Journal of Retina-Vitreous, 2023
openaire   +1 more source

Recognition and treatment of polypoidal choroidal vasculopathy and age-related macular degeneration in British Columbia. [PDF]

Int J Retina Vitreous
Lee Y, Rahman S, Tao BK, Fang T, Akil H, Ferrara D, Lam S, Navajas EV.   +7 more
europepmc   +1 more source

The <i>CFH-CFHR5</i> Locus in Wet Age-Related Macular Degeneration, Polypoidal Choroidal Vasculopathy, and Central Serous Chorioretinopathy. [PDF]

Ophthalmol Sci
Chen ZJ, Yu J, Ho M, Ng DSC, Brelen ME, Young AL, Yam JCS, Tham CC, Pang CP, Chen LJ.   +9 more
europepmc   +1 more source

Combined Therapy Versus Fortified Anti-VEGF Monotherapy in Type C Polypoidal Choroidal Vasculopathy: Long-Term Outcomes and Exploratory Biomarker Insights. [PDF]

Int J Mol Sci
Chao WW, Chao HW, Chao HM.
europepmc   +1 more source

Polypoidal Choroidal Vasculopathy

Ophthalmology Retina
Kelvin Y.C. Teo, Jin Zhi Zhao, Gerd Klose, Won Ki Lee, Chui Ming Gemmy Cheung   +4 more
  +4 more sources

Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy. [PDF]

Pharmaceuticals (Basel)
Fukuda Y, Sakurada Y, Kotoda Y, Kimura M, Kashiwagi K.   +4 more
europepmc   +1 more source